Skip to main content

Table 1 Baseline clinical and laboratory characteristics

From: BK viruria and viremia in children with systemic lupus erythematosus

Clinical findings At time of enrollment
(N =32)
Female (%) 26 (81.3%)
Age (years) 16.0
Weight (kg) 61.5 +/- 20.35
Ethnicity (%)
 African American 9 (28%)
 Caucasian 12 (37.5%)
 Hispanic/Other 11 (34.3%)
Age at diagnosis of SLE (years) 13.67
Age at enrollment (years) 16.0
Duration of SLE (Months) 22.9 +/- 20.51
New onset SLE (%) 4 (12.5)
Lupus nephritis WHO* (%)
 I 4 (12.5)
 II 2 (6.3)
 III 1 (3.1)
 III/V 1 (3.1)
 IV 11 (34.4)
 V 4 (12.5)
No renal biopsy 9 (28.1)
H/O antiphospholipid syndrome 1
H/O neuropsychiatric manifestation/CNS Lupus 6
H/O Vasculitis 4
H/O Arthritis 25
H/O Serositis 3
H/O Pulmonary hemorrhage 1
H/O Cytopenia 22
H/O Raynaud’s phenomeonoN 3
H/O Positive anti-double stranded DNA 22
Positive ANA 32
Ribonuceloprotein 21
Laboratory findings At time of enrollment [mean]
Hemoglobin (g/dl) 12.40
White blood counT (X 109/L) 5.75
Platelet count (X 109/L) 255
Serum creatinine (mg/dl) 0.64
Complement 3 (g/dl) 110
Complement 4 (g/dl) 19
CD3 1004
CD19 0
IGG 820
IGA 128
IGM 29
Urinalysis
 Hematuria (%) 5 (15.6)
 Proteinuria (%) 6 (18.75)
 Normal (%) 21 (65.6)
  1. *WHO—World Health Organization